Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus - PubMed (original) (raw)

Comparative Study

. 1993 Dec;143(6):1649-56.

Affiliations

Comparative Study

Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus

Y Nakamura et al. Am J Pathol. 1993 Dec.

Abstract

Advanced glycosylation end products (AGEs) accumulate on long-lived extracellular matrix proteins and have been implicated in the micro- and macrovascular complications of diabetes mellitus. Within the arterial wall, AGE-modified proteins increase vascular permeability, inactivate nitric oxide activity, and induce the release of growth-promoting cytokines. Recently developed anti-AGE antibodies were used in an immunohistochemical analysis of coronary arteries obtained from type II diabetic and nondiabetic patients. High levels of AGE reactivity were observed within the atherosclerotic plaque present in vessels from selected patients with diabetes. Considered together with the pathological effects of AGEs on vascular wall homeostasis, these data support the role of advanced glycosylation in the rapidly progressive atherosclerosis associated with diabetes mellitus.

PubMed Disclaimer

Similar articles

Cited by

References

    1. N Engl J Med. 1989 Apr 6;320(14):915-24 - PubMed
    1. Carbohydr Res. 1987 Sep 15;167:211-20 - PubMed
    1. Diabetes. 1957 Mar-Apr;6(2):159-67 - PubMed
    1. Proc Natl Acad Sci U S A. 1984 Jan;81(2):583-7 - PubMed
    1. Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12043-7 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources